Axitinib and Nivolumab for the Treatment of Mucosal Melanoma

Summary

The researchers are doing this study to find out whether the combination of axitinib and nivolumab is an effective and safe treatment for people with advanced or metastatic mucosal melanoma that has not been treated before. The researchers think that a combination of axitinib and nivolumab may help people with this disease because both drugs target and block proteins that play a role in cancer cell survival and growth. The researchers think the drugs may be more effective if given in combination rather than on their own.

Timeline

Start

2022-05-17

Primary completion

2027-05

Completion

2027-05

Drugs

Indications